Bedaquiline Fumarate B097-10MG

产品介绍

Bedaquiline Fumarate (TMC-207) is a synthetic diarylquinoline made from equimolar amounts of Bedaquiline and Fumaric Acid. It acts as a proton-translocating ATP synthetase inhibitor. As an antimycobacterial and antitubercular agen, it inhibits the growth of Mycobacterium tuberculosis, the causal agent of tuberculosis. It was first described in 2004 by Janssen Phamaceuticals and is manufactured by Johnson &Johnson, and approved by the FDA in 2012, the first antitubercular agent in over 40 years.